Jefferies Downgrades CytomX Therapeutics to Hold, Lowers Price Target to $2
Jefferies analyst Roger Song downgrades CytomX Therapeutics (NASDAQ:CTMX) from Buy to Hold and lowers the price target from $12 to $2.
Gordon Haskett Downgrades Kohl’s to Hold, Announces $30 Price Target
Gordon Haskett analyst Chuck Grom downgrades Kohl's (NYSE:KSS) from Accumulate to Hold and announces $30 price target.
Raymond James Downgrades PacWest Banc to Market Perform
Raymond James analyst David Long downgrades PacWest Banc (NASDAQ:PACW) from Strong Buy to Market Perform.
Raymond James Downgrades Horizon Bancorp to Outperform, Lowers Price Target to $22
Raymond James analyst David Long downgrades Horizon Bancorp (NASDAQ:HBNC) from Strong Buy to Outperform and lowers the price target from $23 to $22.
Raymond James Downgrades Lakeland Bancorp to Outperform, Lowers Price Target to $17
Raymond James analyst William Wallace downgrades Lakeland Bancorp (NASDAQ:LBAI) from Strong Buy to Outperform and lowers the price target from $20 to $17.
Wolfe Research Downgrades Southern Copper to Underperform
Wolfe Research analyst Timna Tanners downgrades Southern Copper (NYSE:SCCO) from Peer Perform to Underperform.
Raymond James Downgrades SmartFinancial to Outperform, Lowers Price Target to $27
Raymond James analyst William Wallace downgrades SmartFinancial (NASDAQ:SMBK) from Strong Buy to Outperform and lowers the price target from $33 to $27.
Raymond James Downgrades First Commonwealth to Market Perform
Raymond James analyst David Feaster downgrades First Commonwealth (NYSE:FCF) from Outperform to Market Perform.
Raymond James Downgrades CapStar Finl Hldgs to Market Perform
Raymond James analyst William Wallace downgrades CapStar Finl Hldgs (NASDAQ:CSTR) from Outperform to Market Perform.
Raymond James Downgrades Hilltop Holdings to Underperform
Raymond James analyst Michael Rose downgrades Hilltop Holdings (NYSE:HTH) from Market Perform to Underperform.